Annual Current Liabilities
$3.26 M
+$2.05 M+168.26%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual total current liabilities is $3.26 million, with the most recent change of +$2.05 million (+168.26%) on December 31, 2023.
- During the last 3 years, COCP annual current liabilities has risen by +$1.90 million (+140.21%).
- COCP annual current liabilities is now -69.85% below its all-time high of $10.82 million, reached on December 31, 2012.
Performance
COCP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.95 M
-$706.00 K-26.60%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly total current liabilities is $1.95 million, with the most recent change of -$706.00 thousand (-26.60%) on September 30, 2024.
- Over the past year, COCP quarterly current liabilities has increased by +$24.00 thousand (+1.25%).
- COCP quarterly current liabilities is now -87.26% below its all-time high of $15.29 million, reached on September 30, 2013.
Performance
COCP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
COCP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +168.3% | +1.3% |
| 3 y3 years | +140.2% | +60.2% |
| 5 y5 years | +109.5% | +60.2% |
COCP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +168.3% | -40.3% | +60.2% |
| 5 y | 5-year | at high | +168.3% | -40.3% | +60.2% |
| alltime | all time | -69.8% | >+9999.0% | -87.3% | +7983.0% |
Cocrystal Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.95 M(-26.6%) |
| Jun 2024 | - | $2.65 M(+11.6%) |
| Mar 2024 | - | $2.38 M(-27.1%) |
| Dec 2023 | $3.26 M(+168.3%) | $3.26 M(+69.5%) |
| Sep 2023 | - | $1.92 M(+21.2%) |
| Jun 2023 | - | $1.59 M(-49.5%) |
| Mar 2023 | - | $3.15 M(+158.6%) |
| Dec 2022 | $1.22 M(-21.3%) | $1.22 M(-24.9%) |
| Sep 2022 | - | $1.62 M(-42.4%) |
| Jun 2022 | - | $2.81 M(+80.6%) |
| Mar 2022 | - | $1.56 M(+0.8%) |
| Dec 2021 | $1.54 M(+13.8%) | $1.54 M(+25.8%) |
| Sep 2021 | - | $1.23 M(-48.4%) |
| Jun 2021 | - | $2.38 M(+63.3%) |
| Mar 2021 | - | $1.46 M(+7.3%) |
| Dec 2020 | $1.36 M(-40.6%) | $1.36 M(-48.0%) |
| Sep 2020 | - | $2.61 M(-11.2%) |
| Jun 2020 | - | $2.94 M(+52.9%) |
| Mar 2020 | - | $1.93 M(-15.8%) |
| Dec 2019 | $2.29 M(+46.8%) | $2.29 M(+8.6%) |
| Sep 2019 | - | $2.10 M(+13.5%) |
| Jun 2019 | - | $1.85 M(+5.8%) |
| Mar 2019 | - | $1.75 M(+12.6%) |
| Dec 2018 | $1.56 M(+8.4%) | $1.56 M(+36.9%) |
| Sep 2018 | - | $1.14 M(+8.0%) |
| Jun 2018 | - | $1.05 M(-22.5%) |
| Mar 2018 | - | $1.36 M(-5.5%) |
| Dec 2017 | $1.44 M(-29.5%) | $1.44 M(-18.2%) |
| Sep 2017 | - | $1.76 M(-2.4%) |
| Jun 2017 | - | $1.80 M(-11.2%) |
| Mar 2017 | - | $2.03 M(-0.6%) |
| Dec 2016 | $2.04 M | $2.04 M(-35.3%) |
| Sep 2016 | - | $3.15 M(-6.9%) |
| Jun 2016 | - | $3.38 M(-42.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $5.89 M(-12.1%) |
| Dec 2015 | $6.70 M(-26.8%) | $6.70 M(+61.4%) |
| Sep 2015 | - | $4.15 M(-43.5%) |
| Jun 2015 | - | $7.35 M(-49.8%) |
| Mar 2015 | - | $14.65 M(+60.0%) |
| Dec 2014 | $9.16 M(+2272.3%) | $9.16 M(+19.6%) |
| Sep 2014 | - | $7.66 M(+10.8%) |
| Jun 2014 | - | $6.91 M(-45.0%) |
| Mar 2014 | - | $12.55 M(+3152.6%) |
| Dec 2013 | $386.00 K(-96.4%) | $386.00 K(-97.5%) |
| Sep 2013 | - | $15.29 M(+51.2%) |
| Jun 2013 | - | $10.11 M(+9.7%) |
| Mar 2013 | - | $9.21 M(-14.9%) |
| Dec 2012 | $10.82 M(+48.7%) | $10.82 M(+99.6%) |
| Sep 2012 | - | $5.42 M(-46.1%) |
| Jun 2012 | - | $10.05 M(-6.7%) |
| Mar 2012 | - | $10.77 M(+48.0%) |
| Dec 2011 | $7.28 M(+43.3%) | $7.28 M(-6.6%) |
| Sep 2011 | - | $7.80 M(+3.4%) |
| Jun 2011 | - | $7.54 M(+223.1%) |
| Mar 2011 | - | $2.33 M(-54.0%) |
| Dec 2010 | $5.08 M(+8656.2%) | $5.08 M(+6591.2%) |
| Sep 2010 | - | $75.90 K(+19.7%) |
| Jun 2010 | - | $63.40 K(+18.9%) |
| Mar 2010 | - | $53.30 K(-8.1%) |
| Dec 2009 | $58.00 K(+38.4%) | $58.00 K(+11.3%) |
| Sep 2009 | - | $52.10 K(+5.3%) |
| Jun 2009 | - | $49.50 K(+6.9%) |
| Mar 2009 | - | $46.30 K(+10.5%) |
| Dec 2008 | $41.90 K(+73.9%) | $41.90 K(+9.1%) |
| Sep 2008 | - | $38.40 K(+7.6%) |
| Jun 2008 | - | $35.70 K(-1.4%) |
| Mar 2008 | - | $36.20 K(+50.2%) |
| Dec 2007 | $24.10 K | $24.10 K |
FAQ
- What is Cocrystal Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma annual current liabilities year-on-year change?
- What is Cocrystal Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly current liabilities year-on-year change?
What is Cocrystal Pharma annual total current liabilities?
The current annual current liabilities of COCP is $3.26 M
What is the all time high annual current liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high annual total current liabilities is $10.82 M
What is Cocrystal Pharma annual current liabilities year-on-year change?
Over the past year, COCP annual total current liabilities has changed by +$2.05 M (+168.26%)
What is Cocrystal Pharma quarterly total current liabilities?
The current quarterly current liabilities of COCP is $1.95 M
What is the all time high quarterly current liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly total current liabilities is $15.29 M
What is Cocrystal Pharma quarterly current liabilities year-on-year change?
Over the past year, COCP quarterly total current liabilities has changed by +$24.00 K (+1.25%)